Elysium Company
Breakthroughs in aging research are no longer a myth of science fiction but scientific fact. Elysium makes first-of-their-kind health products and technologies backed by partnerships with institutions at the forefront of aging research.
Investors
Connections from
Founded Date:
2014-01-01
Total Funding:
71209000
Funding Status:
Late Stage Venture
Number Of Exists:
11-50
Technology:
Clinical Data Management Platforms
Last Funding Type:
Series C
Investors Number:
16
Last Funding Date:
2021-09-21
Industry:
Digital Biomarkers
Headquarters:
New York, New York, United States
Estimated Revenue:
$1M to $10M